NCT03425513View on ClinicalTrials.gov

Hepatitis B Virus Prevalence and Risk Factors in Belgium

CompletedOBSERVATIONAL

Enrollment

1,131

Participants

Timeline

Start Date

May 12, 2017

Primary Completion Date

November 27, 2017

Study Completion Date

November 27, 2017

Conditions

Hepatitis B

Interventions

DIAGNOSTIC_TEST

Hepatitis B serology

A serum specimen will be taken and assessed for hepatitis B serology (HBsAg and anti-HBc antibodies).

OTHER

Questionnaire

Participants will be asked to fill in a questionnaire regarding demographic characteristics, known viral hepatitis status and risk factors for HBV infection.

Trial Locations (1)

3600

Ziekenhuis Oost-Limburg, Genk

All Listed Sponsors

lead

Hasselt University

OTHER

NCT03425513 - Hepatitis B Virus Prevalence and Risk Factors in Belgium | Biotech Hunter | Biotech Hunter